https://clinicaltrials.gov/study/NCT06815575
I am ready to begin.
@RaceOncology
How much information can be shared about the dose escalations at this stage?
Are the 5 dose escalations all Q3W, or are there opportunities for multiple day dosing? D2Q3W or D3Q3W?
RAC-010: First in-human CPACS Phase 1a/b clinical trial in combination with Doxorubicin
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.010(0.84%) |
Mkt cap ! $205.0M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.17 | $105.7K | 89.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9130 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 1644 | 1 |
View Market Depth
| Last trade - 13.38pm 07/08/2025 (20 minute delay) ? |
| RAC (ASX) Chart |